Journal article

Feasibility of 5-fluorouracil pharmacokinetic monitoring using the My-5FU PCM (TM) system in a quaternary oncology centre

Michael Moloney, David Faulkner, Emma Link, Danny Rischin, Ben Solomon, Annette M Lim, John R Zalcberg, Michael Jefford, Michael Michael

Cancer Chemotherapy and Pharmacology | SPRINGER | Published : 2018

DOI: 10.1007/s00280-018-3679-4

Citation metrics

1Web of Science
1Scopus

Keywords

Aged
Blood Specimen Collection
Fluorouracil
Drug-Related Side Effects and Adverse Reactions
Feasibility
Phase-Ii
Pilot Projects
Continuous-Infusion
Female
Humans
Neoplasms
Dihydropyrimidine Dehydrogenase-Deficiency
Body-Surface Area
Oncology
Pharmacokinetics
Drug Monitoring
Ambulatory Care
Metastatic Colorectal-Cancer
Male
1st-Line Treatment
Oncology Service, Hospital
Life Sciences & Biomedicine
Squamous-Cell Cancer
Area Under Curve
Patient Compliance
Specimen Handling
Science & Technology
Infusions, Intravenous
Antineoplastic Combined Chemotherapy Protocols
Pharmacology & Pharmacy
Anticancer Drugs
Fluorouracil Dose Adjustment
Randomized-Trial
Feasibility Studies